Architectural control of metabolic plasticity in epithelial cancer cells

Commun Biol. 2021 Mar 19;4(1):371. doi: 10.1038/s42003-021-01899-4.

Abstract

Metabolic plasticity enables cancer cells to switch between glycolysis and oxidative phosphorylation to adapt to changing conditions during cancer progression, whereas metabolic dependencies limit plasticity. To understand a role for the architectural environment in these processes we examined metabolic dependencies of cancer cells cultured in flat (2D) and organotypic (3D) environments. Here we show that cancer cells in flat cultures exist in a high energy state (oxidative phosphorylation), are glycolytic, and depend on glucose and glutamine for growth. In contrast, cells in organotypic culture exhibit lower energy and glycolysis, with extensive metabolic plasticity to maintain growth during glucose or amino acid deprivation. Expression of KRASG12V in organotypic cells drives glucose dependence, however cells retain metabolic plasticity to glutamine deprivation. Finally, our data reveal that mechanical properties control metabolic plasticity, which correlates with canonical Wnt signaling. In summary, our work highlights that the architectural and mechanical properties influence cells to permit or restrict metabolic plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Amino Acids / metabolism
  • Caco-2 Cells
  • Cell Culture Techniques
  • Cell Plasticity*
  • Cell Proliferation
  • Energy Metabolism*
  • Epithelial Cells / metabolism*
  • Epithelial Cells / pathology
  • Gas Chromatography-Mass Spectrometry
  • Glucose / metabolism
  • Glycolysis
  • Humans
  • MCF-7 Cells
  • Metabolomics
  • Mutation
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Oxidative Phosphorylation
  • Phenotype
  • Proto-Oncogene Proteins p21(ras) / genetics
  • Time Factors
  • Tumor Microenvironment
  • Wnt Signaling Pathway

Substances

  • Amino Acids
  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)
  • Glucose

Grants and funding